HeartBeam (BEAT) Accumulated Depreciation (2025 - 2026)
HeartBeam's (BEAT) quarterly Accumulated Depreciation came in at $129000.0 in Q2 2026, up 174.47% quarter-over-quarter from $47000.0 in Q4 2025.
Powered by 
Analysis
HeartBeam (BEAT) Accumulated Depreciation (2025 - 2026) Analysis & Trends
HeartBeam (BEAT) has reported Accumulated Depreciation for 2 consecutive years, with $129000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Accumulated Depreciation changed N/A year-over-year to $129000.0 in Q2 2026; TTM through Jun 2026 was $129000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $47000.0, changed N/A from the prior year.
- Accumulated Depreciation was $129000.0 for Q2 2026 at HeartBeam, up from $47000.0 in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $129000.0 in Q2 2026 and troughed at $47000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | HeartBeam | 24.23 Mn | 24.23 Mn | - |